[1]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.701-705
[2]Patent:US2008/280948,2008,A1.Locationinpatent:Page/Pagecolumn22
690632-25-8 | (4-Methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methanamine | AA005YGM | MFCD03791219
690260-94-7 | Ethyl 3-bromo-5-nitrobenzoate | AA005Z3G | MFCD09258760
72016-68-3 | Ethyl 2-(5-bromo-2-methyl-1H-indol-3-yl)acetate | AA005ZVH | MFCD08272278
68087-13-8 | 6-(Methoxymethyl)-2-(methylthio)pyrimidin-4-ol | AA0060P4 | MFCD00052618
936940-46-4 | 4-(AMINOMETHYL)-1-CYCLOPROPYLPYRROLIDIN-2-ONE | AA0061FC | MFCD09055283
7179-99-9 | Oxan-3-ylmethanamine | AA006280 | MFCD07371526
6781-17-5 | 2-(2-Ethoxy-phenoxy)-ethylamine | AA00633L | MFCD06657756
72-55-9 | 1,1-dichloro-2,2-bis(4-chlorophenyl)ethene | AA0063RU | MFCD00000837
66952-36-1 | 1-Bromo-3-(prop-1-yn-1-yl)benzene | AA0064PB | MFCD17677178
953079-94-2 | Pyrrolidine-3-carboxylic acid, HCl | AA0065I8 | MFCD06801272